SEC Form 4 · accession 0001209191-17-044826
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ross Breckenridge
Director
Period of report
Jul 9, 2017
Accepted (ET)
Jul 11, 2017 · 8:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 9, 2017 | A | 6,000 | $0.00 | A | 30,073 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $6.45 | Jul 9, 2017 | A | 10,500 | A | — | Jul 9, 2027 | Common Stock | 10,500 | 10,500 | D |
Explanation of responses
- F1These restricted stock units will vest in full on the earlier of (i) July 9, 2018 or (ii) the day prior to the Issuer's 2018 annual stockholder meeting.
- F2The option shares shall vest in four equal quarterly installments, with the first installment on October 9, 2017.